GSK Beats Wall Street Expectations as Specialty Medicine Sales Drive Massive Growth
Pharmaceutical giant GSK has delivered a robust set of fourth-quarter financial results that comfortably exceeded market expectations, signaling a successful strategic pivot
by 
Josh Weiner
Josh Weiner